RPL-554

Modify Date: 2024-01-15 19:27:44

RPL-554 Structure
RPL-554 structure
Common Name RPL-554
CAS Number 298680-25-8 Molecular Weight 477.56
Density N/A Boiling Point N/A
Molecular Formula C26H31N5O4 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of RPL-554


(E/Z)-Ensifentrine is a dual inhibitor of PDE3/4. (E/Z)-Ensifentrine reduces the inflammatory cells into the airways. (E/Z)-Ensifentrine has bronchodilatory and anti-inflammatory activities in vitro and in vivo model[1].

 Names

Name 2-[9,10-dimethoxy-4-oxo-2-(2,4,6-trimethylphenyl)imino-6,7-dihydropyrimido[6,1-a]isoquinolin-3-yl]ethylurea
Synonym More Synonyms

 RPL-554 Biological Activity

Description (E/Z)-Ensifentrine is a dual inhibitor of PDE3/4. (E/Z)-Ensifentrine reduces the inflammatory cells into the airways. (E/Z)-Ensifentrine has bronchodilatory and anti-inflammatory activities in vitro and in vivo model[1].
Related Catalog
References

[1]. Page CP, et al. Phosphodiesterase inhibitors for the treatment of asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol. 2014;165(3):152-64.  

 Chemical & Physical Properties

Molecular Formula C26H31N5O4
Molecular Weight 477.56
Exact Mass 477.23800
PSA 113.86000
LogP 3.62070

 Synonyms

unii-3e3d8t1gix
rpl-554
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here



Get all suppliers and price by the below link:

RPL-554 suppliers

RPL-554 price

Related Compounds: More...
BP 554 maleate
1221401-95-1
sodium bis[3-[[1-(3-chlorophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]azo]-4-hydroxybenzenesulphonamidato(2-)]cobaltate(1-)
73612-40-5
disodium,chromium,3-[(2Z)-2-(5,8-dichloro-2-oxonaphthalen-1-ylidene)hydrazinyl]-4-hydroxybenzenesulfonamide,(4Z)-4-[(2-hydroxynaphthalen-1-yl)hydrazinylidene]-7-nitro-3-oxonaphthalene-1-sulfonic acid
94276-69-4
Copper, bis(8-quinolinolato-N1,O8)-, reaction products with C8-10-branched fatty acids, tert-decanoic acid, nickel(2+) diacetate, nickel(2+) carbonate (1:1) and nickel hydroxide (Ni(OH)2)
97660-42-9
Magnesium acetate
142-72-3
Cesium hydrogen carbonate
29703-01-3
HCV-1 e2 Protein (554-569)
290362-31-1
Perakizumab
89957-37-9
TRIBUTYL BORANE
122-56-5
4-{2-[5-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)pyridin-2-yl]acetamido}-2-hydroxybutanoic acid
2172273-99-1
3-[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-4-methylpentanamido]hexanoic acid
2171979-43-2
5-({1-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]cyclobutyl}formamido)-4-methylpentanoic acid
2172108-43-7
5-{[1-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)cyclopentyl]formamido}-4-methylpentanoic acid
2172026-44-5
5-{[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)cyclopentyl]formamido}-4-methylpentanoic acid
2171833-58-0
3-({1-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]cyclopentyl}formamido)pentanoic acid
2171994-35-5
1-amino-3-[(1H-pyrazol-1-yl)methyl]cyclohexane-1-carboxamide
2018091-94-4
4-{[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2-methylpropanamido]methyl}oxane-4-carboxylic acid
2171833-67-1
1-({[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-1,3-thiazol-4-yl]formamido}methyl)cyclobutane-1-carboxylic acid
2172108-61-9
1-({[1-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)cyclopentyl]formamido}methyl)cyclobutane-1-carboxylic acid
2172026-73-0